Company

AOA

Rocket Ship Rating

Rocket Ship Rating: 96 out of 100

A ground breaking AI-enabled early detection platform focused on women’s health

Also known as AOA Dx, AOA DX INC.

Medical devices & diagnostics
Women's & family health
AI native

Status: Operatingas of 2026-09-17
Business model: B2B2C
Headquarters: Denver, CO, United States
Founded: 2020
Customers: providers and patients
Legal name: AOA DX INC.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

AOA Dx is pioneering lipidomics to unlock the next generation of biomarkers for early cancer diagnosis.

Funding snapshot

Total raised: $38.7MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Undisclosed, $17.2M2023-07

Funding rounds

Round, 2025: $8.1M2025-10-01, SEC form D sold, 40 investors
Round, 2024: $1.8M2024-12-05, SEC form D sold, 15 investors
Round, 2023: $23.6M2023-07-11, SEC form D sold, 119 investors
$17.2 million financing round closed: $17.2M2023-07, Company stated
Seed: $5M2022-03, Company stated
Round, 2021: $2.6M2021-11-03, SEC form D sold, 33 investors
Pre seed: $2.5M2021-05, Company stated
Round, 2021: $2.5M2021-02-26, SEC form D sold, 38 investors

Products

Other: AKRIVIS GD™
Other: GlycoLocate™